NCBP2 and cancer: Interestingly, we found that NCBP2 expression was significantly negatively correlated with CD8+ T cells, dendritic cells and neutrophils in various cancers, including COAD, HNSC and LUSC (Fig. 5B), which exhibited negatively enriched immune-related pathways (Fig. 4).